Products Categories
CAS No.: | 100981-43-9 |
---|---|
Name: | Ebrotidine |
Article Data: | 4 |
Molecular Structure: | |
Formula: | C14H17BrN6O2S3 |
Molecular Weight: | 477.43 |
Synonyms: | Benzenesulfonamide,N-[[[2-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-,(E)-;Ebrodin;Ebrotidine;FI 3542;Ulsanic; |
Density: | 1.73 g/cm3 |
Melting Point: | 142.5-146℃ |
Boiling Point: | 672.3 °C at 760 mmHg |
Flash Point: | 360.4 °C |
PSA: | 195.24000 |
LogP: | 4.79570 |
The Benzenesulfonamide, N-[[[2-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-, [N(E)]-, with the CAS registry number 100981-43-9, is also known as Ebrotidine. This chemical's molecular formula is C14H17BrN6O2S3 and molecular weight is 477.43. What's more, its IUPAC name is N-(4-Bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1, 3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide. This chemical's classification codes are Anti-ulcer Agents; Drug/Therapeutic Agent; Gastrointestinal Agents; Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists; Neurotransmitter Agents; Reproductive Effect.
Physical properties about Benzenesulfonamide, N-[[[2-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-, [N(E)]- are: (1)ACD/LogP: 3.37; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 1.24; (4)ACD/LogD (pH 7.4): 1.19; (5)ACD/BCF (pH 5.5): 1.58; (6)ACD/BCF (pH 7.4): 1.41; (7)ACD/KOC (pH 5.5): 11.95; (8)ACD/KOC (pH 7.4): 10.69; (9)#H bond acceptors: 8; (10)#H bond donors: 5; (11)#Freely Rotating Bonds: 7; (12)Polar Surface Area: 143.39 Å2; (13)Index of Refraction: 1.739; (14)Molar Refractivity: 110.94 cm3; (15)Molar Volume: 275.1 cm3; (16)Polarizability: 43.98×10-24 cm3; (17)Surface Tension: 72.2 dyne/cm; (18)Density: 1.73 g/cm3; (19)Flash Point: 360.4 °C; (20)Enthalpy of Vaporization: 98.75 kJ/mol; (21)Boiling Point: 672.3 °C at 760 mmHg; (22); (23)Vapour Pressure: 6.2E-18 mmHg at 25 °C.
You can still convert the following datas into molecular structure:
(1) SMILES: Brc1ccc(cc1)S(=O)(=O)N/C=N/CCSCc2nc(/N=C(/N)N)sc2
(2) InChI: InChI=1/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21)
(3) InChIKey: ZQHFZHPUZXNPMF-UHFFFAOYAG
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 366mg/kg (366mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 490, 1997. Link to PubMed | |
mouse | LD50 | intravenous | 107mg/kg (107mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: TREMOR | Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 490, 1997. |
mouse | LD50 | oral | > 2gm/kg (2000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 490, 1997. | |
rat | LD50 | intraperitoneal | 316mg/kg (316mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 490, 1997. | |
rat | LD50 | intravenous | 100mg/kg (100mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA KIDNEY, URETER, AND BLADDER: HEMATURIA | Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 490, 1997. |
rat | LD50 | oral | > 8gm/kg (8000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 47, Pg. 490, 1997. |